New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 21, 2014
10:02 EDTSHPG, MNST, LFL, EZPW, AMX, WFC, RKT, MTRN, IGT, DVA, AUO, SAVE, RH, ITRI, GRT, AMOVOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: AU Optronics (AUO) downgraded to Sell from Neutral at UBS... America Movil downgraded to Underweight from Equal Weight at Morgan Stanley... DaVita (DVA) downgraded to Market Perform from Outperform at Raymond James... EZCORP (EZPW) downgraded to Neutral from Buy at Sidoti... Glimcher Realty Trust (GRT) downgraded to Market Perform at Raymond James... International Game (IGT) downgraded to Hold from Buy at Stifel... Itron (ITRI) downgraded at BofA/Merrill... LATAM Airlines (LFL) downgraded to Neutral from Buy at BofA/Merrill... Materion (MTRN) downgraded to Hold from Buy at KeyBanc... Monster Beverage (MNST) downgraded at Morgan Stanley... Restoration Hardware (RH) downgraded at BB&T... RockTenn (RKT) downgraded to Neutral from Outperform at Macquarie... Shire (SHPG) downgraded to Market Perform from Outperform at Leerink... Spirit Airlines (SAVE) downgraded to Equal-Weight from Overweight at Evercore... Wells Fargo (WFC) downgraded to Hold from Buy at Rafferty Capital.
News For AUO;AMX;AMOV;DVA;EZPW;GRT;IGT;LFL;ITRI;MTRN;MNST;RH;RKT;SHPG;SAVE;WFC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
February 23, 2015
08:05 EDTDVACMS releases preliminary Medicare Advantage rates for 2016
Subscribe for More Information
07:55 EDTSHPGJefferies says other bidders may emerge for Salix
Jefferies says it could envision other bidders emerging for Salix (SLXP) and points out recent media reports have suggested Shire (SHPG) and Endo (ENDP) have considered making a bid for the company. It lists AstraZeneca (AZN) and Takeda as others who could have possible interest in Salix. The firm believes Valeant (VRX) could afford to pay more for Salix should other bidders emerge.
07:49 EDTRKTFebruary fall in paper prices a modest negative, says Jefferies
Jefferies notes that according to PPW, unbleached kraft paperboard and solid unbleached sulfate prices fell modestly in February due to weak frozen food and beverage demand. The firm views the drop in SBS prices as a modest negative for RockTenn (RKT)/MeadWestvaco (MWV), Graphic Packaging (GPK) and International Paper (IP). It feels the impact should be limited, however, given the lag on the pass throughs in the converting business.
February 22, 2015
18:04 EDTSHPGShire completes acquisition of NPS Pharma
Shire (SHPG) announces the successful completion of the tender offer for all of the outstanding shares of NPS Pharmaceuticals (NPSP) and the subsequent acquisition of NPS Pharma.The tender offer expired at 12:00 midnight, New York City time, at the end of Friday, February 20, and was not extended. As of the expiration of the tender offer, a total of approximately 88,869,118 common shares of NPS Pharma had been validly tendered and not withdrawn pursuant to the tender offer, representing approximately 81.7% of the outstanding common shares of NPS Pharma. All shares that were validly tendered and not withdrawn pursuant to the tender offer were accepted for payment. After the acceptance of shares that were validly tendered and not withdrawn pursuant to the tender offer, Shire completed the acquisition of NPS Pharma today through a merger of one of Shire's subsidiaries with and into NPS Pharma. In connection with the merger, all common shares of NPS Pharma that were not accepted for payment in the tender offer (excluding any shares held by NPS Pharma as treasury stock (other than any shares held in an NPS Pharma benefit plan) and any shares with respect to which the holders have properly demanded appraisal rights in accordance with Delaware law) were converted into the right to receive $46.00 per share in cash, without interest and less any applicable withholding taxes, the same price that will be paid for shares accepted for payment in the tender offer. Following completion of the merger, NPS Pharma became a wholly owned subsidiary of Shire and NPS Pharma's shares ceased to be traded on NASDAQ.
15:59 EDTSHPGValeant to buy Salix for $10.1B, FT says
Subscribe for More Information
February 20, 2015
10:01 EDTMTRNOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:22 EDTMNSTMonster Beverage volatility elevated into Q4 and outlook
Subscribe for More Information
07:08 EDTSHPGAmerican Academy of Allergy, Asthma and Immunology to hold annual meeting
2015 Annual Meeting of AAAAI is being held in Houston, Texas on February 20-24.
06:06 EDTMTRNMaterion downgraded to Hold from Buy at Jefferies
Subscribe for More Information
February 19, 2015
08:27 EDTMTRNMaterion sees FY15 adjusted EPS $1.80-$2.00, consensus $2.11
The company comments, "Second half 2014 value-added sales were up 9% over both the prior-year second half and first half of 2014. This high single-digit year-over-year value-added sales growth rate is forecasted to continue into 2015. Additionally, the facility closures and product line rationalization initiatives undertaken in 2013 delivered the expected $0.30 per share net benefit in 2014. The combination of top-line growth and a lower cost structure generated earnings momentum in the second half of 2014, which is expected to continue in 2015. Order entry from automotive electronics has picked up in 1Q15. In addition, we anticipate that our sales for telecommunications infrastructure will be stronger in 2015 as compared to 2014 due to the global buildout of 4G and undersea cable. Offsetting this strength are higher pension expense resulting from lower discount rates and new mortality tables, the strengthening of the U.S. dollar and anticipated softness in the energy market, coupled with slower growth forecasts in Asia and Europe. Despite the above-mentioned headwinds, the company expects at this time adjusted earnings growth of 10-20% in 2015 to the range of $1.80-$2.00 per share."
08:26 EDTMTRNMaterion reports Q4 adjusted EPS 50c, consensus 43c
Subscribe for More Information
06:47 EDTWFCReport shows subprime consumer loans at pre-2007 levels, WSJ says
Equifax (EFX) has released a report stating nearly 40%, or 50M, of auto loans, credit cards, and personal loans during the first 11 months of 2014 were made to subprime customers, the highest levels since the 2007 financial crisis, reports the Wall Street Journal. LendingTree (TREE) Chief Marketing Officer Gabriel Dalporto attributes the growth to nonbank lenders under less regulatory scrutiny than large banks. Publicly traded companies in the space include Bank of America (BAC), Citi (C), Goldman Sachs (GS), JPMorgan (JPM), Morgan Stanley (MS), U.S. Bancorp (USB) and Wells Fargo (WFC). Reference Link
February 18, 2015
17:52 EDTSAVESpirit Airlines reinstated with a Buy at BofA/Merrill
Subscribe for More Information
10:05 EDTRHOn The Fly: Analyst Initiation Summary
Subscribe for More Information
07:29 EDTRHRestoration Hardware initiated with an Outperform at Cowen
Subscribe for More Information
07:21 EDTWFCJPMorgan, Citi top government report of riskiest banks, Reuters reports
Subscribe for More Information
February 17, 2015
18:06 EDTSHPGPaulson & Co gives quarterly update on stakes
Subscribe for More Information
17:29 EDTDVABerkshire Hathaway gives quarterly update on stakes, exits Exxon Mobil
Subscribe for More Information
09:12 EDTSHPGShire multiple poised to expand, says SunTrust
SunTrust believes that Shire's rare disease unit will account for 40% of its 2020 sales, versus the company's estimate of about 35%. As a result, the firm expects the company's multiple to "re-rate." The firm thinks that the company's long-term growth outlook is underappreciated, and it keeps a $262 price target and Buy rating on the shares.
08:17 EDTRKTContainerboard bull Perry Capital trims stakes in RockTenn, KapStone
Subscribe for More Information
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use